Senate Keeps Supply Shortage Language In Draft Stimulus Compromise

By Beth Wang / March 24, 2020 at 5:17 PM
A draft Senate COVID-19 stimulus compromise floated Tuesday (March 24) maintains multiple provisions that would expand requirements for drug makers to report product shortages, give FDA authority to require device makers report shortages and potential supply disruptions, and protect manufacturers of respiratory masks from lawsuits. The draft bill, the Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748), was being hammered out by Senate Republicans and Democrats from both chambers after days of bipartisan disagreement. Title III of the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.